Oracef
Oracef Brand names, Oracef Analogs
Oracef Brand Names Mixture
- None
Oracef Chemical_Formula
C16H17N3O5S
Oracef RX_link
http://www.rxlist.com/cgi/generic/cefadrox.htm
Oracef fda sheet
Oracef msds (material safety sheet)
Oracef Synthesis Reference
L. B. Crast, Jr., U.S. Pat. 3,489,752 (1969)
Oracef Molecular Weight
363.389 g/mol
Oracef Melting Point
197oC
Oracef H2O Solubility
1110 mg/L
Oracef State
Solid
Oracef LogP
-0.355
Oracef Dosage Forms
Capsule; Tablet; Oral liquid
Oracef Indication
For the treatment of the following infections (skin, UTI, ENT) caused by; S. pneumoniae, H. influenzae, staphylococci, S. pyogenes (group A beta-hemolytic streptococci), E. coli, P. mirabilis, Klebsiella sp, coagulase-negative staphylococci and Streptococcus pyogenes
Oracef Pharmacology
Cefadroxil, a first-generation cephalosporin antibiotic, is used to treat urinary tract infections, skin and skin structure infections, pharyngitis, and tonsillitis.
Oracef Absorption
Cefadroxil is well absorbed on oral administration; food does not interfere with its absorption.
Oracef side effects and Toxicity
Nausea, vomiting, diarrhoea, allergic rashes may occur
Oracef Patient Information
Patients should be counseled that intibacterial drugs including DURICEF should only be used to treat bacterial infections. They do not treat viral infections (eg. the common cold). When DURICEF is prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelyhood that bacteria will develop resistance and will not be treatable by DURICEF or other antibacterial drugs in the future.
Oracef Organisms Affected
Enteric bacteria and other eubacteria
